NSE filing, NSE: PAR. Summary written from the filing by ALFA Finder's alert engine.
Par Drugs & Chemicals Ltd: key numbers
- Share price
- ₹120.60
- Market cap
- ₹148.4 Cr
- Revenue (annual)
- ₹103.7 Cr
- Net profit (annual)
- ₹13.11 Cr
- P/E (TTM)
- 10.2×Sector 46.1×
- Promoter holding
- 73.41%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Par Drugs & Chemicals Ltd
All →Par Drugs & Chemicals Board Meeting Date
Par Drugs and Chemicals Limited will hold a board meeting on October 29, 2026, to consider and approve its half-yearly unaudited financial results.
Par Drugs & Chemicals Other Announcement
The company submitted the routine Regulation 74(5) compliance certificate from its RTA regarding share dematerialization for the quarter ended September 30, 2026.
Par Drugs & Chemicals Management Change
Par Drugs re-appointed its statutory auditor and executive director/CEO. These appointments were approved at the company's 27th Annual General Meeting.
Par Drugs & Chemicals Annual General Meeting
Par Drugs and Chemicals Limited held its 27th Annual General Meeting on September 26, 2026. Management reviewed the company's financial performance and business affairs during the session.
Par Drugs & Chemicals Other Announcement
Par Drugs and Chemicals Limited is notifying shareholders about access to the FY 2025-26 Annual Report and 27th AGM notice via web-link.
Par Drugs & Chemicals Management Change
Par Drugs and Chemicals Limited has re-appointed M/s. Siddhpura & Co. as Internal Auditor and M/s. Maulin Shah & Associates as Cost Auditor.
Other board meeting date announcements
All →Lake Shore Realty Board Meeting Date
Lake Shore Realty Ltd has scheduled a board meeting on 02 Nov 2026 to approve unaudited standalone financial results for Q2 H1 FY27. No other agenda items specified beyond routine matters.
GTV Engineering Board Meeting Date
GTV Engineering scheduled a Board Meeting for 5 November 2026 to approve unaudited Q2 and half-year financial results. No new information is disclosed beyond the meeting notice.
Elixir Capital Board Meeting Date
Elixir Capital Ltd notified BSE that its Board will meet on 6 Nov 2026 to consider Q2/H1FY27 results. No financial figures or decisions are reported yet.
Ecofinity Atomix Board Meeting Date
Ecofinity Atomix Ltd intimated BSE of a Board meeting on 7 November 2026 to consider Q2 and H1 FY27 unaudited results. No financial figures are stated.
Gorani Industries Board Meeting Date
Gorani Industries scheduled its Board meeting for 13 November 2026. It will consider the unaudited results for the September quarter and half-year.
Luxury Time Board Meeting Date
Luxury Time Ltd scheduled its board meeting for 3 Nov 2026 to consider H1 results, CFO replacement, and director remuneration. The filing is a prior intimation; no decisions have been made yet.